Recent KRBP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:29:54 PM
- Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation • Business Wire • 08/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 07:04:00 PM
- Kiromic BioPharma Provides Update on Part 1 of the Deltacel-01 Trial • Business Wire • 08/09/2024 12:00:00 PM
- Kiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01 • Business Wire • 08/01/2024 12:00:00 PM
- Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion Phase • Business Wire • 07/18/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2024 08:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2024 09:21:01 PM
- Kiromic BioPharma Provides Updates on its Deltacel-01 Clinical Trial • Business Wire • 06/20/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:32:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:36:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:36:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:30:17 PM
- Kiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical Trial • Business Wire • 06/06/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:13:41 PM
- Kiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical Trial • Business Wire • 05/29/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:03:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 09:00:22 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/20/2024 09:00:06 PM
- Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site • Business Wire • 05/20/2024 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/17/2024 08:43:17 PM
- Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients • Business Wire • 04/24/2024 12:08:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/19/2024 08:30:26 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM